Fanny Rocher

1.2k total citations
58 papers, 547 citations indexed

About

Fanny Rocher is a scholar working on Pharmacology, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Fanny Rocher has authored 58 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 11 papers in Pathology and Forensic Medicine and 10 papers in Neurology. Recurrent topics in Fanny Rocher's work include Drug-Induced Adverse Reactions (10 papers), Pharmacovigilance and Adverse Drug Reactions (10 papers) and Multiple Sclerosis Research Studies (7 papers). Fanny Rocher is often cited by papers focused on Drug-Induced Adverse Reactions (10 papers), Pharmacovigilance and Adverse Drug Reactions (10 papers) and Multiple Sclerosis Research Studies (7 papers). Fanny Rocher collaborates with scholars based in France, United States and Netherlands. Fanny Rocher's co-authors include Christine Lebrun‐Frénay, Milou‐Daniel Drici, Alexandre O. Gérard, Nadège Parassol, Laurent Chouchana, Alexandre Destère, Vincent Esnault, Mikaël Cohen, Michel Lantéri‐Minet and S. Thureau and has published in prestigious journals such as Circulation, Neurology and Frontiers in Immunology.

In The Last Decade

Fanny Rocher

52 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fanny Rocher France 12 143 115 108 78 78 58 547
Gabriella di Mauro Italy 14 120 0.8× 37 0.3× 73 0.7× 64 0.8× 80 1.0× 32 671
Alexandre O. Gérard France 11 212 1.5× 48 0.4× 66 0.6× 40 0.5× 66 0.8× 37 475
Marion Lepelley France 16 75 0.5× 51 0.4× 38 0.4× 61 0.8× 141 1.8× 42 574
María Sáinz-Gil Spain 11 61 0.4× 33 0.3× 31 0.3× 64 0.8× 37 0.5× 49 436
Dolores Montero Spain 16 310 2.2× 48 0.4× 105 1.0× 32 0.4× 69 0.9× 35 1.3k
Montserrat García Spain 11 31 0.2× 67 0.6× 43 0.4× 19 0.2× 60 0.8× 30 482
Arantza Sanvisens Spain 17 129 0.9× 198 1.7× 38 0.4× 57 0.7× 39 0.5× 61 745
Michele Fusaroli Italy 13 49 0.3× 17 0.1× 184 1.7× 28 0.4× 131 1.7× 45 562
Dinah Foer United States 13 56 0.4× 28 0.2× 23 0.2× 45 0.6× 25 0.3× 45 654
Giuseppe Roberto Italy 15 18 0.1× 95 0.8× 117 1.1× 21 0.3× 108 1.4× 50 726

Countries citing papers authored by Fanny Rocher

Since Specialization
Citations

This map shows the geographic impact of Fanny Rocher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanny Rocher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanny Rocher more than expected).

Fields of papers citing papers by Fanny Rocher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanny Rocher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanny Rocher. The network helps show where Fanny Rocher may publish in the future.

Co-authorship network of co-authors of Fanny Rocher

This figure shows the co-authorship network connecting the top 25 collaborators of Fanny Rocher. A scholar is included among the top collaborators of Fanny Rocher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fanny Rocher. Fanny Rocher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gérard, Alexandre O., et al.. (2025). Safety profile of belatacept in a real-life setting: disproportionality analysis of the WHO pharmacovigilance database. BMC Pharmacology and Toxicology. 26(1). 147–147.
2.
Gérard, Alexandre O., et al.. (2025). Evaluating and leveraging large language models in clinical pharmacology and therapeutics assessment: From exam takers to exam shapers. British Journal of Clinical Pharmacology. 1 indexed citations
3.
Destère, Alexandre, et al.. (2024). An artificial intelligence algorithm for co‐clustering to help in pharmacovigilance before and during the COVID‐19 pandemic. British Journal of Clinical Pharmacology. 90(5). 1258–1267. 2 indexed citations
4.
Cohen, Mikaël, et al.. (2024). Dental Adverse Effects of Anti-CD20 Therapies. Neurology and Therapy. 13(3). 917–930. 2 indexed citations
5.
6.
Martel, Arnaud, Fanny Rocher, & Alexandre O. Gérard. (2024). Teprotumumab for the Treatment of Thyroid Eye Disease: Why Should We Keep Our Eyes “Wide Open”?—A Clinical and Pharmacovigilance Point of View. Journal of Personalized Medicine. 14(10). 1027–1027. 1 indexed citations
7.
Grandvuillemin, Aurélie, et al.. (2023). Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemic. Therapies. 78(5). 523–529. 5 indexed citations
8.
Fernandez, Arnaud, Alexandre O. Gérard, Fanny Rocher, et al.. (2022). Adverse Drug Reactions of Olanzapine, Clozapine and Loxapine in Children and Youth: A Systematic Pharmacogenetic Review. Pharmaceuticals. 15(6). 749–749. 3 indexed citations
9.
10.
Gérard, Alexandre O., Bruno Giordana, Fanny Rocher, et al.. (2022). Medications as a Trigger of Sleep-Related Eating Disorder: A Disproportionality Analysis. Journal of Clinical Medicine. 11(13). 3890–3890. 9 indexed citations
11.
Gérard, Alexandre O., et al.. (2022). Case Report: Severe Hypercalcemia Following Vitamin D Intoxication in an Infant, the Underestimated Danger of Dietary Supplements. Frontiers in Pediatrics. 10. 816965–816965. 6 indexed citations
12.
Gérard, Alexandre O., et al.. (2022). Calcitonin gene-related peptide-targeting drugs and Raynaud’s phenomenon: a real-world potential safety signal from the WHO pharmacovigilance database. The Journal of Headache and Pain. 23(1). 53–53. 30 indexed citations
13.
Gérard, Alexandre O., Bruno Giordana, Fanny Rocher, et al.. (2022). COVID-19 Vaccine-Associated Transient Global Amnesia: A Disproportionality Analysis of the WHO Safety Database. Frontiers in Pharmacology. 13. 909412–909412. 3 indexed citations
14.
Gérard, Alexandre O., Marine Andreani, Nadège Parassol, et al.. (2021). Immune checkpoint inhibitors-induced nephropathy: a French national survey. Cancer Immunology Immunotherapy. 70(11). 3357–3364. 11 indexed citations
15.
Valnet‐Rabier, Marie‐Blanche, et al.. (2021). Patterns of medication errors involving pediatric population reported to the French Medication Error Guichet. Pharmacy Practice. 19(2). 2360–2360. 8 indexed citations
16.
Rocher, Fanny, et al.. (2021). Eye amputation following lifitegrast treatment for ocular graft-versus-host disease: First case report. Journal Français d Ophtalmologie. 44(5). 652–657. 3 indexed citations
17.
Monpoux, Fabrice, et al.. (2020). Tolerance induction to deferasirox in a child with transfusion-dependent beta thalassemia. Archives de Pédiatrie. 28(1). 101–103.
18.
Gérard, Alexandre O., et al.. (2020). Spontaneous reported cardiotoxicity induced by lopinavir/ritonavir in COVID-19. An alleged past-resolved problem. International Journal of Cardiology. 324. 255–260. 16 indexed citations
19.
Lafeuillade, Alain, et al.. (2019). Are current guidelines adapted for patient eligibility to PrEP? A case report. BMC Infectious Diseases. 19(1). 601–601.
20.
Rocher, Fanny, et al.. (2017). Pertinence comparée des notifications d’effets indésirables de patients et professionnels de santé. Therapies. 72(6). 625–633. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gabriella di Mauro Breakdown of academic impact, for papers by Alexandre O. Gérard Breakdown of academic impact, for papers by Marion Lepelley Breakdown of academic impact, for papers by María Sáinz-Gil Breakdown of academic impact, for papers by Dolores Montero Breakdown of academic impact, for papers by Montserrat García Breakdown of academic impact, for papers by Arantza Sanvisens Breakdown of academic impact, for papers by Michele Fusaroli Breakdown of academic impact, for papers by Dinah Foer Breakdown of academic impact, for papers by Giuseppe Roberto
Rankless by CCL
2026